(47) evaluated surgical specimens from 111 patients with HER2-negative breast cancer, in which high CD8 and low FOXP3 cell infiltration after chemotherapy were significantly associated with improved RFS (p = 0.02) and OS (p = 0.002). This evidence concerns the gene CD8A and breast cancer.